235 related articles for article (PubMed ID: 10617691)
1. The CB(1) cannabinoid receptor juxtamembrane C-terminal peptide confers activation to specific G proteins in brain.
Mukhopadhyay S; McIntosh HH; Houston DB; Howlett AC
Mol Pharmacol; 2000 Jan; 57(1):162-70. PubMed ID: 10617691
[TBL] [Abstract][Full Text] [Related]
2. CB1 receptor-G protein association. Subtype selectivity is determined by distinct intracellular domains.
Mukhopadhyay S; Howlett AC
Eur J Biochem; 2001 Feb; 268(3):499-505. PubMed ID: 11168387
[TBL] [Abstract][Full Text] [Related]
3. Functional coupling of the human dopamine D2 receptor with G alpha i1, G alpha i2, G alpha i3 and G alpha o G proteins: evidence for agonist regulation of G protein selectivity.
Gazi L; Nickolls SA; Strange PG
Br J Pharmacol; 2003 Mar; 138(5):775-86. PubMed ID: 12642378
[TBL] [Abstract][Full Text] [Related]
4. G protein G alpha q/11 and G alpha i1,2 are activated by pancreastatin receptors in rat liver: studies with GTP-gamma 35S and azido-GTP-alpha-32P.
Santos-Alvarez J; Sánchez-Margalet V
J Cell Biochem; 1999 Jun; 73(4):469-77. PubMed ID: 10733341
[TBL] [Abstract][Full Text] [Related]
5. Agonist selective regulation of G proteins by cannabinoid CB(1) and CB(2) receptors.
Glass M; Northup JK
Mol Pharmacol; 1999 Dec; 56(6):1362-9. PubMed ID: 10570066
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Gi by the CB1 cannabinoid receptor C-terminal juxtamembrane region: structural requirements determined by peptide analysis.
Mukhopadhyay S; Cowsik SM; Lynn AM; Welsh WJ; Howlett AC
Biochemistry; 1999 Mar; 38(11):3447-55. PubMed ID: 10079092
[TBL] [Abstract][Full Text] [Related]
7. Coupling efficacy and selectivity of the human mu-opioid receptor expressed as receptor-Galpha fusion proteins in Escherichia coli.
Stanasila L; Lim WK; Neubig RR; Pattus F
J Neurochem; 2000 Sep; 75(3):1190-9. PubMed ID: 10936202
[TBL] [Abstract][Full Text] [Related]
8. C-terminal truncated cannabinoid receptor 1 coexpressed with G protein trimer in Sf9 cells exists in a precoupled state and shows constitutive activity.
Chillakuri CR; Reinhart C; Michel H
FEBS J; 2007 Dec; 274(23):6106-15. PubMed ID: 17986258
[TBL] [Abstract][Full Text] [Related]
9. Solubilization of the cannabinoid receptor from rat brain and its functional interaction with guanine nucleotide-binding proteins.
Houston DB; Howlett AC
Mol Pharmacol; 1993 Jan; 43(1):17-22. PubMed ID: 8423766
[TBL] [Abstract][Full Text] [Related]
10. Effect of halothane on the guanosine 5' triphosphate binding activity of G-protein alphai subunits.
Streiff J; Jones K; Perkins WJ; Warner DO; Jones KA
Anesthesiology; 2003 Jul; 99(1):105-11. PubMed ID: 12826849
[TBL] [Abstract][Full Text] [Related]
11. RGS17/RGSZ2, a novel regulator of Gi/o, Gz, and Gq signaling.
Mao H; Zhao Q; Daigle M; Ghahremani MH; Chidiac P; Albert PR
J Biol Chem; 2004 Jun; 279(25):26314-22. PubMed ID: 15096504
[TBL] [Abstract][Full Text] [Related]
12. The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt.
Gómez del Pulgar T; Velasco G; Guzmán M
Biochem J; 2000 Apr; 347(Pt 2):369-73. PubMed ID: 10749665
[TBL] [Abstract][Full Text] [Related]
13. The CB(1) cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase.
Rueda D; Galve-Roperh I; Haro A; Guzmán M
Mol Pharmacol; 2000 Oct; 58(4):814-20. PubMed ID: 10999952
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel site within G protein alpha subunits important for specificity of receptor-G protein interaction.
Heydorn A; Ward RJ; Jorgensen R; Rosenkilde MM; Frimurer TM; Milligan G; Kostenis E
Mol Pharmacol; 2004 Aug; 66(2):250-9. PubMed ID: 15266015
[TBL] [Abstract][Full Text] [Related]
15. Galpha(i2) but not Galpha(i3) is required for muscarinic inhibition of contractility and calcium currents in adult cardiomyocytes.
Nagata K; Ye C; Jain M; Milstone DS; Liao R; Mortensen RM
Circ Res; 2000 Nov; 87(10):903-9. PubMed ID: 11073886
[TBL] [Abstract][Full Text] [Related]
16. Functional capabilities of an N-formyl peptide receptor-G(alpha)(i)(2) fusion protein: assemblies with G proteins and arrestins.
Shi M; Bennett TA; Cimino DF; Maestas DC; Foutz TD; Gurevich VV; Sklar LA; Prossnitz ER
Biochemistry; 2003 Jun; 42(24):7283-93. PubMed ID: 12809484
[TBL] [Abstract][Full Text] [Related]
17. Selective interaction of AGS3 with G-proteins and the influence of AGS3 on the activation state of G-proteins.
Bernard ML; Peterson YK; Chung P; Jourdan J; Lanier SM
J Biol Chem; 2001 Jan; 276(2):1585-93. PubMed ID: 11042168
[TBL] [Abstract][Full Text] [Related]
18. Pertussis toxin-insensitive activation of the heterotrimeric G-proteins Gi/Go by the NG108-15 G-protein activator.
Ribas C; Takesono A; Sato M; Hildebrandt JD; Lanier SM
J Biol Chem; 2002 Dec; 277(52):50223-5. PubMed ID: 12426323
[TBL] [Abstract][Full Text] [Related]
19. Protean agonism at the dopamine D2 receptor: (S)-3-(3-hydroxyphenyl)-N-propylpiperidine is an agonist for activation of Go1 but an antagonist/inverse agonist for Gi1,Gi2, and Gi3.
Lane JR; Powney B; Wise A; Rees S; Milligan G
Mol Pharmacol; 2007 May; 71(5):1349-59. PubMed ID: 17287401
[TBL] [Abstract][Full Text] [Related]
20. The regulator of G protein signaling RGS4 selectively enhances alpha 2A-adreoreceptor stimulation of the GTPase activity of Go1alpha and Gi2alpha.
Cavalli A; Druey KM; Milligan G
J Biol Chem; 2000 Aug; 275(31):23693-9. PubMed ID: 10807934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
